Effect of iron deficiency on placental cytokine expression and fetal growth in the pregnant rat.
Iron deficiency anemia is the most common nutritional disorder in the world. Anemia is especially serious during pregnancy, with deleterious consequences for both the mother and her developing fetus. We have developed a model to investigate the mechanisms whereby fetal growth and development are affected by maternal anemia. Weanling rats were fed a control or iron-deficient diet before and throughout pregnancy and were killed at Day 21. Dams on the deficient diet had lower hematocrits, serum iron concentrations, and liver iron levels. Similar results were recorded in the fetus, except that the degree of deficiency was markedly less, indicating compensation by the placenta. No effect was observed on maternal weight or the number and viability of fetuses. The fetuses from iron-deficient dams, however, were smaller than controls, with higher placental:fetal ratios and relatively smaller livers. Iron deficiency increased levels of tumor necrosis factor alpha (TNFalpha) only in the trophoblast giant cells of the placenta. In contrast, levels of type 1 TNFalpha receptor increased significantly in giant cells, labyrinth, cytotrophoblast, and fetal vessels. Leptin levels increased significantly in labyrinth and marginally (P = 0.054) in trophoblast giant cells. No change was observed in leptin receptor levels in any region of the placentas from iron-deficient dams. The data show that iron deficiency not only has direct effects on iron levels and metabolism but also on other regulators of growth and development, such as placental cytokines, and that these changes may, in part at least, explain the deleterious consequences of maternal iron deficiency during pregnancy.
Gambling
Lorraine
L
The Rowett Research Institute, Bucksburn, Aberdeen AB21 9SB, United Kingdom.
Charania
Zehane
Z
Hannah
Lisa
L
Antipatis
Christos
C
Lea
Richard G
RG
McArdle
Harry J
HJ
D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D001772:Blood Cell Count; D001835:Body Weight / Q000187:drug effects; D016207:Cytokines / Q000096:biosynthesis*; D004032:Diet; D005314:Embryonic and Fetal Development / Q000502:physiology*; D005260:Female; D005298:Fertility / Q000502:physiology; D006400:Hematocrit; D007150:Immunohistochemistry; D007501:Iron / Q000097:blood / Q000378:metabolism; D000090463:Iron Deficiencies; D020738:Leptin / Q000378:metabolism; D008098:Litter Size; D008099:Liver / Q000378:metabolism; D010920:Placenta / Q000166:cytology / Q000378:metabolism*; D011247:Pregnancy; D051381:Rats; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism; D047888:Receptors, Tumor Necrosis Factor, Type I; D013054:Spectrophotometry, Atomic; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D015703:Antigens, CD; D016207:Cytokines; D020738:Leptin; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; D014409:Tumor Necrosis Factor-alpha; D007501:Iron